Thank you, Horacio, and good morning, everyone. I too am very pleased with our operating and financial results. We had a strong fourth quarter, closing out an excellent fiscal year 2023 at both the top and the bottom lines. The momentum we built on both the supply side and the demand side, positions us well for the future as you will see in our fiscal year 2024 guidance. Booz Allen continues to produce industry-leading organic growth. Our margins are underpinned by the quality of our offerings and the strength of our execution. We are augmenting and accelerating our organic performance with a patient and disciplined capital deployment approach, and as a result, we remain on track to deliver on our multi-year investment thesis. I have a lot to cover today, so I will start by hitting the highlights of our fourth quarter performance then turn to our fiscal year 2023 results and finally close with our fiscal year 2024 guidance. Our fourth quarter results were in-line with our expectations as we finished the fiscal year strong while investing in the talent and the capabilities to drive future growth. In the fourth quarter, we delivered overall revenue growth of 8.7% year-over-year and organic revenue growth of 7.7%. This performance was driven by continued headcount growth, a solid book-to-bill ratio of 1.47 times, and client staff utilization that declined in the fourth quarter but is in line with our current growth posture. Adjusted EBITDA for the quarter grew to $231 million, an increase of 13% year-over-year. This was a function of our overall growth, strong contract-level performance, and continued efforts to operate more efficiently. This translated to us generating $1.01 in ADEPS for the quarter, a growth of 17% year-over-year. In the quarter, we returned $191 million of capital to investors, primarily through a combination of dividends and share repurchases. And finally, we added over 800 net client staff in the quarter, a Q4 record due to strong hiring and seasonally low attrition. Now please turn to slide six, as I discuss our full fiscal year 2023 results. Total revenue for fiscal year 2023 grew 10.7% year-over-year to approximately $9.3 billion exceeding the top end of our guidance. Organic revenue growth was 9% year-over-year. And revenue excluding billable expenses grew 9.5% to approximately $6.5 billion. Our growth in fiscal year 2023 was broad-based. In Defense, revenue grew approximately 7% year-over-year. We are expanding our work at the core of national defense priorities, leveraging emerging technologies such as those Horacio described to transform missions and provide our Warfighters with decision advantage. Hiring remains a focus for our defense leaders, as their success to date has allowed us to ramp up new work and convert backlog. This business continues to accelerate. In Civil, revenue grew by approximately 19% year-over-year. This growth was particularly strong in our health and citizen services accounts and across our cyber and digital services offerings. We continue to see growth in our civil markets with a healthy proposal pipeline and the talent needed to convert on existing backlog. In Intelligence, revenue grew by approximately 7% year-over-year. This business delivered flat revenue growth in the fourth quarter due to tough year-over-year comps in billable expenses and cost recovery on certain contracts. We expect modest growth in the first quarter of fiscal year 2024, but this will taper during the year as our Intelligence business has seen higher-than-anticipated contract turnover. Our intel market leaders are focused on realizing the full value of the EverWatch transaction and repositioning our work against critical defense intelligence, national intelligence and cyber emissions. And finally, our global commercial revenue increased approximately 6% year-over-year. Our work providing critical cyber and incident response services to commercial clients and its connection to our government cyber mission remains a small but strategically important part of our overall portfolio. On the labor supply side, we ended the fiscal year with approximately 29,000 client staff, an increase of 10.6% year-over-year. Total headcount, inclusive of corporate staff, increased only 8.9% reflecting our ongoing focus on managing the business more efficiently. We continue to see both hiring momentum and significantly lower attrition rates compared to prior years. On the demand side, our strong backlog of work and a robust proposal pipeline provides good near-term visibility. We ended fiscal year 2023 with a trailing 12-month book-to-bill ratio of 1.18 times. Our total backlog was $31.2 billion, up approximately 6.7% year-over-year. Funded backlog grew 24.5% to $4.6 billion, unfunded backlog fell 4.1% to $9.5 billion and priced options grew 9.3% to $17.1 billion. Looking forward, our qualified pipeline of $46 billion is up approximately 14% compared to this time last year. With the current year budget in place, we are leaning into this pipeline to win as much work as possible and to get it on contract in advance of the coming budget negotiations. At the bottom line, we earned $1.014 billion in adjusted EBITDA in fiscal year 2023, finishing at the high end of our guidance range. This is a year-over-year increase of 8.4%. Our adjusted EBITDA margin of 11% was in line with our expectations and our guided range. Our net income decreased 41.9% year-over-year to $271 million. This was primarily a result of the $350 million legal reserve we recorded in connection with the ongoing DoJ matter in fiscal year 2023. Adjusted net income, which excludes this reserve, was up approximately 6.5% year-over-year to $605 million. Diluted earnings per share decreased 41% year-over-year to $2.03, primarily as a result of the aforementioned legal reserve. Excluding this reserve, adjusted diluted earnings per share or ADEPS increased 8.3% year-over-year to $4.56. Turning now to the balance sheet. We ended fiscal year 2023 with a cash balance of $405 million and a $1 billion untapped revolver. Free cash flow for the year was $527 million. This was the result of $603 million of cash generated from operating activities net of $76 million of CapEx. Our operating cash flow reflects our strong operating performance, offset by higher cash taxes due to the impact of Section 174, higher interest and higher spending on growth-oriented investments in our people and our business. Our net debt at the end of the fiscal year was approximately $2.4 billion and our net leverage ratio was approximately 2.4 times adjusted EBITDA. Turning to slide eight. In fiscal year 2023, we deployed approximately $905 million of capital in a measured and balanced manner. This included approximately $440 million connected with the EverWatch acquisition, $236 million in cash dividends and $224 million in share repurchases at an average price of $91.83 per share. We remain patient and disciplined in our capital deployment approach as we navigate macroeconomic conditions, budget uncertainty and a challenging M&A environment. However, we remain focused on finding small to midsized tuck-in acquisitions that are consistent with our culture and VoLT strategy, active accelerants to growth and meet our financial parameters. Today, I am pleased to announce that our Board has approved a quarterly dividend of $0.47 per share that will be payable on June 30th to stockholders of record as of June 15th. Please turn now to slide nine for a discussion of our fiscal year 2024 outlook. As Horacio noted, we are entering into a period of uncertainty in our external environment. This is a familiar pattern for us. In recent years, we have typically guided to and planned for a strong first half and a more uncertain second half of our fiscal year. We are doing the same this year, as you will see reflected in our guidance and operating priorities. That said, we have significant momentum in our business, on the demand side, on the supply side and in our operations and we are well positioned relative to long-term demand trends. This supports fiscal year 2024 growth and profit guidance above the organic targets and our current investment thesis. At the top line, we are guiding to revenue growth of 7% to 11%, 6% to 10% of which will be organic. We expect to start the year at or above the top end of this range. Where we fall within this range for the fiscal year will depend on several factors, including the pace at which we can win work and get it on contract, the outcome of government funding and budgetary debates and the timing and extent to which we add consulting headcount throughout the year. At this point, we are targeting 3% to 5% growth for the full year, in line with historic patterns, but likely weighted towards the first half. We expect adjusted EBITDA margins in the high 10% to 11% range. This translates to an adjusted EBITDA dollar range of between $1.075 billion and $1.105 billion or approximately 6% to 9% growth year-over-year. We expect ADEPS of between $4.80 per share and $4.95 per share or growth of approximately 5% to 9% year-over-year. Lastly, we expect operating cash flow of between $500 million and $600 million and free cash flow of between $400 million and $500 million. This assumes a CapEx spend of approximately $100 million and this cash guidance reflects EBITDA growth offset by continued investments to grow our business, higher interest costs and temporarily higher cash taxes. In closing, I want to recognize our Booz Allen team for their hard work, dedication to mission and commitment to the firm. It is through their efforts that we had an excellent finish to our fiscal year 2023, built momentum that supports continued outperformance in fiscal year 2024 are well positioned against the most pressing needs of our clients and remain on track to achieve our multiyear investment thesis. With that, operator, let's open the line for questions.